Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Fort Lauderdale, Fla., Feb. 24, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD Care software, has been named one of the best places to work in South Florida by the...
-
New York, Feb. 24, 2023 (GLOBE NEWSWIRE) -- “The Omega 3 Supplements Market Size valued at US$ 6.60 bn in 2022, and is estimated to reach US$ 12.96 bn by 2030, with a growing healthy CAGR of 8.8%...
-
New York, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The Electronic Health Records (EHR) Market size was escalated at US$ 27.88 billion at the end of 2022 and is projected to reach US$ 45.80 billion by 2030,...
-
New York, Feb. 24, 2023 (GLOBE NEWSWIRE) -- “The Type 1 Diabetes Market Size was valued at US$ 7.59 billion in 2022, and is projected to reach US$ 13.64 billion by 2030, with a growing CAGR of 7.6%...
-
New York, USA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Digital Diabetes Management Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Digital diabetes...
-
New York, NY, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM), in collaboration with the Accreditation Council for Graduate Medical Education (ACGME), this year has...
-
London, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The WHO reported nearly 262 million asthma patients worldwide in the year 2019, further following around 455,000 mortalities due to asthma the same year. On...
-
MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a...
-
New York, NY, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By...
-
TARRYTOWN, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use...